232 related articles for article (PubMed ID: 34023336)
1. R (-)-methoxetamine exerts rapid and sustained antidepressant effects and fewer behavioral side effects relative to S (+)-methoxetamine.
Botanas CJ; Perez Custodio RJ; Kim HJ; de la Pena JB; Sayson LV; Ortiz DM; Kim M; Lee HJ; Acharya S; Kim KM; Lee CJ; Ryu JH; Lee YS; Cheong JH
Neuropharmacology; 2021 Aug; 193():108619. PubMed ID: 34023336
[TBL] [Abstract][Full Text] [Related]
2. The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT
Sayson LV; Botanas CJ; Custodio RJP; Abiero A; Kim M; Lee HJ; Kim HJ; Yoo SY; Lee KW; Ryu HW; Acharya S; Kim KM; Lee YS; Cheong JH
Psychopharmacology (Berl); 2019 Jul; 236(7):2201-2210. PubMed ID: 30891619
[TBL] [Abstract][Full Text] [Related]
3. Methoxetamine produces rapid and sustained antidepressant effects probably via glutamatergic and serotonergic mechanisms.
Botanas CJ; Bryan de la Peña J; Custodio RJ; Joy Dela Peña I; Kim M; Woo T; Kim HJ; Kim HI; Chang Cho M; Lee YS; Cheong JH
Neuropharmacology; 2017 Nov; 126():121-127. PubMed ID: 28867363
[TBL] [Abstract][Full Text] [Related]
4. New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT
Marti M; Talani G; Miliano C; Bilel S; Biggio F; Bratzu J; Diana M; De Luca MA; Fattore L
Exp Neurol; 2021 Nov; 345():113836. PubMed ID: 34384790
[TBL] [Abstract][Full Text] [Related]
5. Methoxetamine: A foe or friend?
Botanas CJ; de la Peña JB; Kim HJ; Lee YS; Cheong JH
Neurochem Int; 2019 Jan; 122():1-7. PubMed ID: 30365979
[TBL] [Abstract][Full Text] [Related]
6. The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents.
Halberstadt AL; Slepak N; Hyun J; Buell MR; Powell SB
Psychopharmacology (Berl); 2016 Apr; 233(7):1215-25. PubMed ID: 26758284
[TBL] [Abstract][Full Text] [Related]
7. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K
Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718
[TBL] [Abstract][Full Text] [Related]
8. Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: Evidence of its abuse potential.
Botanas CJ; de la Peña JB; Dela Peña IJ; Tampus R; Yoon R; Kim HJ; Lee YS; Jang CG; Cheong JH
Pharmacol Biochem Behav; 2015 Jun; 133():31-6. PubMed ID: 25792291
[TBL] [Abstract][Full Text] [Related]
9. A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.
Zanos P; Nelson ME; Highland JN; Krimmel SR; Georgiou P; Gould TD; Thompson SM
eNeuro; 2017; 4(1):. PubMed ID: 28275719
[TBL] [Abstract][Full Text] [Related]
10. Neuropharmacological characterization of the new psychoactive substance methoxetamine.
Hondebrink L; Kasteel EEJ; Tukker AM; Wijnolts FMJ; Verboven AHA; Westerink RHS
Neuropharmacology; 2017 Sep; 123():1-9. PubMed ID: 28454981
[TBL] [Abstract][Full Text] [Related]
11. Methoxetamine: from drug of abuse to rapid-acting antidepressant.
Coppola M; Mondola R
Med Hypotheses; 2012 Oct; 79(4):504-7. PubMed ID: 22819129
[TBL] [Abstract][Full Text] [Related]
12. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
[TBL] [Abstract][Full Text] [Related]
13. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
[TBL] [Abstract][Full Text] [Related]
14. Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings.
Zanda MT; Fadda P; Chiamulera C; Fratta W; Fattore L
Behav Pharmacol; 2016 Sep; 27(6):489-96. PubMed ID: 27128862
[TBL] [Abstract][Full Text] [Related]
15. The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats.
Costa G; Serra M; Pintori N; Casu MA; Zanda MT; Murtas D; De Luca MA; Simola N; Fattore L
Neuropharmacology; 2019 Jan; 144():219-232. PubMed ID: 30366005
[TBL] [Abstract][Full Text] [Related]
16. Methoxetamine affects brain processing involved in emotional response in rats.
Zanda MT; Fadda P; Antinori S; Di Chio M; Fratta W; Chiamulera C; Fattore L
Br J Pharmacol; 2017 Oct; 174(19):3333-3345. PubMed ID: 28718892
[TBL] [Abstract][Full Text] [Related]
17. Cortical and raphe GABA
Pham TH; Defaix C; Nguyen TML; Mendez-David I; Tritschler L; David DJ; Gardier AM
Pharmacol Biochem Behav; 2020 May; 192():172913. PubMed ID: 32201299
[TBL] [Abstract][Full Text] [Related]
18. Ketamine: A tale of two enantiomers.
Jelen LA; Young AH; Stone JM
J Psychopharmacol; 2021 Feb; 35(2):109-123. PubMed ID: 33155503
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.
Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Han M; Hashimoto K
Psychopharmacology (Berl); 2015 Dec; 232(23):4325-35. PubMed ID: 26337614
[TBL] [Abstract][Full Text] [Related]
20. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ
Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
